Skip to content

星期五, 3 二月, 2023

Latest:

智慧財產
媒體新聞
獲獎實績
學術發表

長弘生物科技股份有限公司

研發抗癌藥物的明日之星

關於長弘
創辦人的話
產品研發
智慧財產
最新消息
聯絡我們
EN

學術發表

學術發表

2022-05-312022-05-31 jacky

1. Targeting the Axl

EN NEWS

Local delivery therapy of Cerebraca® Wafer being highlighted in the natural review
2022-06-27
Case report – Cerebraca® Wafer implantation combined with CIK therapy for the treatment of recurrent Glioblastoma revealed superior clinical outcome (overall survival extended for more than 24 months).
2022-06-27
Case report – Cerebraca® Wafer implantation for the treatment of un-resectable cervical spine Glioblastoma resulted in the tumor regression.
2022-06-27
Outstanding clinical outcomes were published in various journals. We have listed as follows:
2022-06-27

Copyright © 2023 長弘生物科技股份有限公司. All rights reserved.
Theme: ColorMag by ThemeGrill. Powered by WordPress.